Hims & Hers Health (HIMS) Research & Development (2021 - 2026)

Hims & Hers Health has disclosed Research & Development across 6 years of filings, most recently posting $54.9 million for Q2 2026.

• In Q2 2026, Research & Development rose 45.06% year-over-year to $54.9 million; the TTM figure through Jun 2026 stood at $183.4 million (up 62.85% YoY), while the FY2025 annual figure was $149.3 million, up 89.42% from the prior year.
• Research & Development came in at $54.9 million for Q2 2026 at Hims & Hers Health, up from $46.9 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $54.9 million in Q2 2026 to a low of $6.1 million in Q1 2022.
• Average Research & Development over 5 years is $22.6 million, with a median of $17.0 million recorded in 2024.
• Year-over-year, Research & Development increased 27.8% in 2022 and jumped 102.89% in 2025.
• Over 5 years, Research & Development stood at $8.3 million in 2022, then jumped by 61.29% to $13.4 million in 2023, then surged by 77.17% to $23.7 million in 2024, then surged by 72.48% to $41.0 million in 2025, then soared by 34.03% to $54.9 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $54.9 million in Q2 2026, $46.9 million in Q1 2026, and $41.0 million in Q4 2025.